Vor Biopharma Inc. announced a stock option repricing on December 5, 2025, reducing the exercise price of around 5.2 million options to $8.18 per share, previously priced between $17.80 and $47.60. This move aims to motivate employees while adhering to retention periods for those affected by the changes.